Ignite Creation Date:
2025-12-26 @ 1:18 PM
Ignite Modification Date:
2025-12-29 @ 6:31 PM
Study NCT ID:
NCT00331006
Status:
COMPLETED
Last Update Posted:
2013-06-11
First Post:
2006-05-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab to Treat Severe Hemophilia A
Sponsor:
Carelon Research
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
374
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None